The Effect of Long-acting Muscarinic Antagonist on Airway Inflammation Through Leukotrienes

被引：0
|
作者：
Matsuyama, T. [1 ]
Machida, K. [1 ]
Matsuyama, H. [1 ]
Dotake, Y. [1 ]
Takagi, K. [1 ]
Inoue, H. [1 ]
机构：
[1] Kagoshima Univ, Dept Pulm Med, Grad Sch Med & Dent Sci, Kagoshima, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1300
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Issues on Safety of Long-Acting Muscarinic Antagonist
    Lee, Yang Deok
    Cho, Yongseon
    Han, Min Soo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2011, 70 (05) : 384 - 389
  • [2] The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
    Matera, Maria Gabriella
    Rinaldi, Barbara
    Calabrese, Cecilia
    Belardo, Carmela
    Calzetta, Luigino
    Cazzola, Mario
    Page, Clive
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [3] The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
    Maria Gabriella Matera
    Barbara Rinaldi
    Cecilia Calabrese
    Carmela Belardo
    Luigino Calzetta
    Mario Cazzola
    Clive Page
    Respiratory Research, 25
  • [4] Long-acting muscarinic antagonist regulates group 2 innate lymphoid cell-dependent airway eosinophilic inflammation
    Matsuyama, Takahiro
    Machida, Kentaro
    Motomura, Yasutaka
    Takagi, Koichi
    Doutake, Yoichi
    Tanoue-Hamu, Asako
    Kondo, Kiyotaka
    Mizuno, Keiko
    Moro, Kazuyo
    Inoue, Hiromasa
    ALLERGY, 2021, 76 (09) : 2785 - 2796
  • [5] Onset of Effect of Aclidinium, a Novel, Long-Acting Muscarinic Antagonist, in Patients with COPD
    Vestbo, Jorgen
    Vogelmeier, Claus
    Creemers, Jacques
    Falques, Meritxell
    Ribera, Anna
    Gil, Esther Garcia
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (05) : 331 - 336
  • [6] Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
    Yamada, Hideyasu
    Hida, Norihito
    Hizawa, Nobuyuki
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3141 - 3147
  • [7] COMPARISON OF MONOTHERAPY WITH A LONG-ACTING MUSCARINIC ANTAGONIST VERSUS COMBINATION THERAPY WITH A LONG-ACTING MUSCARINIC ANTAGONIST PLUS A LONG-ACTING BETA2-AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Yosuke, Tanaka
    Mitsunori, Hino
    Naomi, Onda
    Hiroyuki, Takoi
    Seiji, Kosaihira
    Norihisa, Motohashi
    Akihiko, Gemma
    RESPIROLOGY, 2014, 19 : 122 - 122
  • [8] Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients
    Decramer, Marc
    Maltais, Francois
    Feldman, Gregory
    Brooks, Jean
    Harris, Stephanie
    Mehta, Rashmi
    Crater, Glenn
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2013, 185 (02) : 393 - 399
  • [9] Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
    Hamelmann, Eckard
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [10] The effect of long-acting β2-agonists on airway inflammation in asthmatic patients
    Howarth, PH
    Beckett, P
    Dahl, R
    RESPIRATORY MEDICINE, 2000, 94 : S22 - S25
12345